Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Operating Expenses (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Operating Expenses was $3 billion in Q2 2026, up 15.5% from $2.6 billion a year earlier and up 1.2% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Operating Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regeneron Pharmaceuticals' Operating Expenses was $11.69 billion through Jun 30, 2026, up 12.7% year-over-year; for FY2025, it came in at $10.77 billion, up 5.4% from FY2024.

  • Operating Expenses has now increased for seven consecutive years, with a five-year compound annual growth rate of 17.0% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $10.21 billion in FY2024 (+12.6%), $9.07 billion in FY2023 (+22.0%), $7.43 billion in FY2022 (+4.3%) and $7.12 billion in FY2021 (+44.8%).
  • Quarterly Operating Expenses has moved between $1.61 billion (Q3 2021) and $3 billion (Q4 2025) over five years.
  • Compared with a year earlier, Operating Expenses has increased for 14 straight quarters, with growth averaging 10.6% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 84.1%); the worst was Q2 2022 (a decline of 2.5%).
  • Per Business Quant data, REGN's Operating Expenses in the three quarters before Q2 2026 was $2.96 billion (Q1 2026), $3 billion (Q4 2025) and $2.73 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 10.12 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 10.56 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 9.70 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 18.20 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 6.68 Bn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 3.00 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.00 Bn
Mar 31, 2026 2.96 Bn
Dec 31, 2025 3.00 Bn
Sep 30, 2025 2.73 Bn
Jun 30, 2025 2.60 Bn
Mar 31, 2025 2.44 Bn
Dec 31, 2024 2.80 Bn
Sep 30, 2024 2.54 Bn
Jun 30, 2024 2.48 Bn
Mar 31, 2024 2.39 Bn
Dec 31, 2023 2.46 Bn
Sep 30, 2023 2.25 Bn
Jun 30, 2023 2.14 Bn
Mar 31, 2023 2.22 Bn
Dec 31, 2022 2.27 Bn
Sep 30, 2022 1.71 Bn
Jun 30, 2022 1.75 Bn
Mar 31, 2022 1.71 Bn
Dec 31, 2021 2.31 Bn
Sep 30, 2021 1.61 Bn
API Access

Regeneron Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=REGN&period=max&api_key=YOUR_API_KEY